RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges-Reference-Cited by-同舟云学术

RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges

Published:2022-11 Issue:6 Volume:1877 Page:188810
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Servetto Alberto,Esposito Daniela,Ferrara Roberto,Signorelli Diego,Belli Stefania,Napolitano Fabiana,Santaniello Antonio,Ciciola Paola,Formisano Luigi,Bianco Roberto

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference155 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

3. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2018

4. Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives;Imyanitov;Crit. Rev. Oncol. Hematol.,2021

5. Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the;Kalemkerian;J. Clin. Oncol.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective RET Kinase Inhibitors and Lung Cancer;New England Journal of Medicine;2023-11-16

2. Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series;Clinical Lung Cancer;2023-11

3. First-line versus second-line use of pralsetinib in treatment of rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis;Translational Lung Cancer Research;2023-09

4. Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies;Cancers;2023-07-19

5. Case report: Savolitinib induced severe adverse reactions resembling septic shock in an HIV-1–positive patient with advanced non-small cell lung cancer;Frontiers in Pharmacology;2023-02-02